SouthState’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.32K Sell
10
-9
-47% -$2.22K ﹤0.01% 945
2026
Q2
$4.58K Hold
19
– – ﹤0.01% 814
2026
Q1
$3.59K Hold
19
– – ﹤0.01% 806
2025
Q4
$3.23K Sell
19
-14
-42% -$2.15K ﹤0.01% 889
2025
Q3
$4.35K Sell
33
-104
-76% -$12.5K ﹤0.01% 782
2025
Q2
$14.5K Buy
137
+100
+270% +$10.9K ﹤0.01% 712
2025
Q1
$4.59K Buy
+37
New +$4.83K ﹤0.01% 1008

Other funds holding JAZZ

SouthState's JAZZ Position: Q3 2026 in Review

SouthState reduced its Jazz Pharmaceuticals (JAZZ) stake by 47% in Q3 2026, selling an estimated $2.22K and leaving 10 shares worth $2.32K. The position accounts for ﹤0.01% of the portfolio, ranked #945.

SouthState first reported a position in JAZZ in Q1 2025 and has held it in 7 quarters since. The position peaked at $14.5K in Q2 2025. 542 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • SouthState held 10 shares of Jazz Pharmaceuticals worth $2.32K as of Q3 2026.
  • SouthState sold 9 Jazz Pharmaceuticals shares in Q3 2026, an estimated $2.22K.
  • Jazz Pharmaceuticals made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #945 holding.
  • SouthState first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • SouthState's Jazz Pharmaceuticals position peaked at $14.5K in Q2 2025.
  • 542 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.